Sarepta Therapeutics, Inc. (SRPT)
20.89
+0.55
(+2.70%)
USD |
NASDAQ |
Dec 19, 09:44
Sarepta Therapeutics Gross Profit (TTM): 1.791B for Sept. 30, 2025
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Pfizer Inc. | 43.40B |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Amgen, Inc. | 25.29B |
| Bristol Myers Squibb Co. | 30.90B |
| Alnylam Pharmaceuticals, Inc. | 2.693B |